BOUL — Boule Diagnostics AB Balance Sheet
0.000.00%
- SEK209.70m
- SEK394.50m
- SEK558.46m
- 38
- 53
- 10
- 21
Annual balance sheet for Boule Diagnostics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 33 | 38.2 | 96.9 | 37.3 | 22.7 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 100 | 140 | 156 | 168 | 161 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 197 | 242 | 338 | 280 | 255 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 54.7 | 47.4 | 58.6 | 44.3 | 39.5 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 480 | 572 | 760 | 755 | 517 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 153 | 211 | 201 | 203 | 263 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 210 | 276 | 297 | 280 | 321 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 269 | 296 | 463 | 475 | 196 |
| Total Liabilities & Shareholders' Equity | 480 | 572 | 760 | 755 | 517 |
| Total Common Shares Outstanding |